A Research Study to Evaluate Experimental PLX PAD Injections for the Treatment of Severe COVID-19
Summary
- Eligibility
- for people ages 40-80 (full criteria)
- Location
- at UC Davis UC Irvine
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pluristem Ltd.
- Links
- Related Info
- ID
- NCT04389450
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated